Department of Molecular Sciences, Uppsala BioCentrum, Swedish University of Agricultural Sciences, P.O. Box 7015, 750 07, Uppsala, Sweden.
Ultupharma AB, Södra Rudbecksgatan 13, 752 36, Uppsala, Sweden.
Amino Acids. 2021 Mar;53(3):323-331. doi: 10.1007/s00726-021-02951-7. Epub 2021 Feb 13.
Isopedopeptins are antibiotic cyclic lipodepsipeptides containing the subsequence L-Thr-L-2,3-diaminopropanoic acid-D-Phe-L-Val/L-3-hydroxyvaline. Acidic hydrolysis of isopedopeptins in DO showed the D-Phe residues to racemize extensively in peptides with L-3-hydroxyvaline but not in peptides with L-Val. Similarly, one Leu residue in pedopeptins, which are related peptides containing the subsequence Leu-2,3-diaminopropanoic acid-Leu-L-Val/L-3-hydroxyvaline, was found to racemize in peptides with L-3-hydroxyvaline. Model tetrapeptides, L-Ala-L-Phe-L-Val/3-hydroxyvaline-L-Ala, gave the corresponding results, i.e. racemization of L-Phe only when linked to a L-3-hydroxyvaline. We propose the racemization to proceed via an oxazoline intermediate involving Phe/Leu and the L-3-hydroxyvaline residues. The 3-hydroxyvaline residue may form a stable tertiary carbocation by loss of the sidechain hydroxyl group as water after protonation. Elimination of the Phe/Leu H-2 and ring-closure from the carbonyl oxygen onto the carbocation results in the suggested oxazoline intermediate. The reversed reaction leads to either retained or inversed configuration of Phe/Leu. Such racemization during acidic hydrolysis may occur whenever a 3-hydroxyvaline residue or any amino acid that can form a stable carbocation on the C-3, is present in a peptide. The proposed mechanism for racemization was supported by incorporation of O in the 3-hydroxyvaline sidechain when the acidic hydrolysis was performed in HO/HO (1:1). The 2,3-diaminopropanoic residues of isopedopeptins and pedopeptins were also found to racemize during acidic hydrolysis, as previously described. Based on the results, the configuration of the Leu and 2,3-diaminopropanoic acid residues of the pedopeptins were reassigned to be L-Leu and D-Leu, and 2 × L-2,3-diaminopropanoic acid.
异缬氨酰二肽是一种含有 L-Thr-L-2,3-二氨基丙酸-D-Phe-L-Val/L-3-羟基缬氨酸的抗生素环状脂肽。在 DO 中进行异缬氨酰二肽的酸水解时,发现含有 L-3-羟基缬氨酸的肽中 D-Phe 残基广泛外消旋化,但含有 L-Val 的肽中则没有。同样,与含有 Leu-2,3-二氨基丙酸-Leu-L-Val/L-3-羟基缬氨酸的相关肽 Pedopeptins 有关的一个 Leu 残基,在含有 L-3-羟基缬氨酸的肽中也被发现外消旋化。模型四肽 L-Ala-L-Phe-L-Val/3-hydroxyvaline-L-Ala 也给出了相应的结果,即只有与 L-3-羟基缬氨酸相连时,L-Phe 才会外消旋化。我们提出该外消旋化是通过涉及 Phe/Leu 和 L-3-羟基缬氨酸残基的噁唑啉中间体进行的。3-羟基缬氨酸残基可能通过质子化后失去侧链羟基形成水而形成稳定的三级碳正离子。从羰基氧到碳正离子的 Phe/Leu H-2 的消除和环化导致了所建议的噁唑啉中间体。逆反应导致 Phe/Leu 的保留或反转构型。只要在肽中存在 3-羟基缬氨酸残基或任何可以在 C-3 上形成稳定碳正离子的氨基酸,在酸性水解过程中就可能发生这种外消旋化。当在 HO/HO(1:1)中进行酸性水解时,在 3-羟基缬氨酸侧链中掺入 O 支持了外消旋化的机制。如前所述,异缬氨酰二肽和 Pedopeptins 的 2,3-二氨基丙酸残基也在酸性水解过程中外消旋化。基于这些结果,重新分配了 Pedopeptins 的 Leu 和 2,3-二氨基丙酸残基的构型为 L-Leu 和 D-Leu,以及 2×L-2,3-二氨基丙酸。